These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1352672)
1. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease. Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672 [TBL] [Abstract][Full Text] [Related]
2. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype. Negishi I; Kato G; Moriwaki S; Ishikawa O Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522 [TBL] [Abstract][Full Text] [Related]
3. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727 [TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of xeroderma pigmentosum group A in Japan. Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms. Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292 [TBL] [Abstract][Full Text] [Related]
6. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum]. Mimaki T; Tanaka K; Nagai A; Mino M Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a splicing mutation in group A xeroderma pigmentosum. Satokata I; Tanaka K; Miura N; Miyamoto I; Satoh Y; Kondo S; Okada Y Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9908-12. PubMed ID: 1702221 [TBL] [Abstract][Full Text] [Related]
8. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670 [TBL] [Abstract][Full Text] [Related]
9. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A. Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188 [TBL] [Abstract][Full Text] [Related]
11. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum. Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells. Marionnet C; Benoit A; Benhamou S; Sarasin A; Stary A J Mol Biol; 1995 Oct; 252(5):550-62. PubMed ID: 7563073 [TBL] [Abstract][Full Text] [Related]
13. U.v.-hypermutability of xeroderma pigmentosum cells demonstrated with a DNA-based mutation system. Steingrimsdottir H; Beare D; Carr AM; Cole J; Lehmann AR Oncogene; 1995 May; 10(10):2057-66. PubMed ID: 7761106 [TBL] [Abstract][Full Text] [Related]
14. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein. States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271 [TBL] [Abstract][Full Text] [Related]
15. Three nonsense mutations responsible for group A xeroderma pigmentosum. Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102 [TBL] [Abstract][Full Text] [Related]
16. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D. Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650 [TBL] [Abstract][Full Text] [Related]
17. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC. Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196 [TBL] [Abstract][Full Text] [Related]
18. DNA-based prenatal carrier detection for group A xeroderma pigmentosum in a chorionic villus sample. Matsumoto N; Saito N; Harada N; Tanaka K; Niikawa N Prenat Diagn; 1995 Jul; 15(7):675-7. PubMed ID: 8532631 [TBL] [Abstract][Full Text] [Related]
19. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients. Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089 [TBL] [Abstract][Full Text] [Related]
20. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome. Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]